Search Results - "Emili, Rita"

KRAS4A and KRAS4B in liquid biopsy of metastatic lung adenocarcinoma patients treated with Pembrolizumab or chemotherapy plus Pembrolizumab by Chiari, Rita, Palladino, Silvia, Emili, Rita, De Lisa, Mariagrazia, Sarti, Donatella, Catalano, Vincenzo, Magnani, Mauro, Graziano, Francesco, Ruzzo, Annamaria

“…KRAS is involved in the stability and expression of PD-L1 . We investigated the expression of circulating mRNA (cmRNA) of KRAS4A and KRAS4B and the possible…”
Get full text

Cancer Related Anemia: An Integrated Multitarget Approach and Lifestyle Interventions by Natalucci, Valentina, Virgili, Edy, Calcagnoli, Federica, Valli, Giacomo, Agostini, Deborah, Zeppa, Sabrina Donati, Barbieri, Elena, Emili, Rita

“…Cancer is often accompanied by worsening of the patient's iron profile, and the resulting anemia could be a factor that negatively impacts antineoplastic…”
Get full text

Home-based lifestyle intervention for breast cancer survivors: A surprising improvement in the quality of life during the first year of COVID-19 pandemic by Vagnini, Denise, Natalucci, Valentina, Moi, Sara, Vallorani, Luciana, Pietrelli, Alice, Panico, Andrea Rocco, Ferri Marini, Carlo, Lucertini, Francesco, Annibalini, Giosuè, Sisti, Davide, Rocchi, Marco Bruno Luigi, Catalano, Vincenzo, Saita, Emanuela, Emili, Rita, Barbieri, Elena

“…The COVID-19 pandemic induced an extraordinary impact on public mental health to a degree not completely understood, especially in vulnerable populations such…”
Get full text

A home-based lifestyle intervention program reduces the tumorigenic potential of triple-negative breast cancer cells by Baldelli, Giulia, Natalucci, Valentina, Ferri Marini, Carlo, Sisti, Davide, Annibalini, Giosuè, Saltarelli, Roberta, Bocconcelli, Matteo, Gentilini, Veronica, Emili, Rita, Rocchi, Marco Bruno Luigi, Lucertini, Francesco, Barbieri, Elena, Brandi, Giorgio, De Santi, Mauro

“…Translational research for the evaluation of physical activity habits and lifestyle modifications based on nutrition and exercise has recently gained…”
Get full text

Movement and health beyond care, MoviS: study protocol for a randomized clinical trial on nutrition and exercise educational programs for breast cancer survivors by Natalucci, Valentina, Ferri Marini, Carlo, De Santi, Mauro, Annibalini, Giosuè, Lucertini, Francesco, Vallorani, Luciana, Panico, Andrea Rocco, Sisti, Davide, Saltarelli, Roberta, Donati Zeppa, Sabrina, Agostini, Deborah, Gervasi, Marco, Baldelli, Giulia, Grassi, Eugenio, Nart, Alessandra, Rossato, Massimo, Biancalana, Vincenzo, Piccoli, Giovanni, Benelli, Piero, Villarini, Anna, Somaini, Matteo, Catalano, Vincenzo, Guarino, Stefania, Pietrelli, Alice, Monaldi, Silvia, Sarti, Donatella, Barocci, Simone, Flori, Marco, Rocchi, Marco Bruno Luigi, Brandi, Giorgio, Stocchi, Vilberto, Emili, Rita, Barbieri, Elena

“…Breast cancer (BC) is the most common invasive cancer in women, and exercise can significantly improve the outcomes of BC survivors. MoviS (Movement and Health…”
Get full text

Changes in gut microbiota composition after 12 weeks of a home-based lifestyle intervention in breast cancer survivors during the COVID-19 lockdown by Donati Zeppa, Sabrina, Natalucci, Valentina, Agostini, Deborah, Vallorani, Luciana, Amatori, Stefano, Sisti, Davide, Rocchi, Marco B. L., Pazienza, Valerio, Perri, Francesco, Villani, Annacandida, Binda, Elena, Panebianco, Concetta, Mencarelli, Gandino, Ciuffreda, Luigi, Ferri Marini, Carlo, Annibalini, Giosué, Lucertini, Francesco, Bartolacci, Alessia, Imperio, Marta, Virgili, Edy, Catalano, Vincenzo, Piccoli, Giovanni, Stocchi, Vilberto, Emili, Rita, Barbieri, Elena

“…Background Breast cancer (BC) is the second-leading cause of cancer-related death worldwide. This study aimed to investigate the effects of a 12-week…”
Get full text

Effect of a lifestyle intervention program's on breast cancer survivors' cardiometabolic health: Two-year follow-up by Natalucci, Valentina, Ferri Marini, Carlo, Lucertini, Francesco, Annibalini, Giosuè, Sisti, Davide, Vallorani, Luciana, Saltarelli, Roberta, Panico, Andrea Rocco, Imperio, Marta, Flori, Marco, Busacca, Paolo, Villarini, Anna, Donati Zeppa, Sabrina, Agostini, Deborah, Monaldi, Silvia, Barocci, Simone, Catalano, Vincenzo, Rocchi, Marco Bruno Luigi, Benelli, Piero, Stocchi, Vilberto, Barbieri, Elena, Emili, Rita

“…The purpose of this study is to assess the cardiometabolic responses of a lifestyle intervention (LI) conducted at home among breast cancer (BC) survivors…”
Get full text

The Role of Autologous Stem Cell Transplantation in the Treatment of Diffuse Large B-Cell Lymphoma by Liberati, Anna Marina, Coaccioli, Stefano, Emili, Rita, Gunnellini, Marco

“…Diffuse large B-cell non-Hodgkin’s lymphoma (DLBCL) accounting for approximately 30% of new lymphoma diagnoses in adult patients. Complete remissions (CRs) can…”
Get full text

Special Attention to Physical Activity in Breast Cancer Patients during the First Wave of COVID-19 Pandemic in Italy: The DianaWeb Cohort by Natalucci, Valentina, Villarini, Milena, Emili, Rita, Acito, Mattia, Vallorani, Luciana, Barbieri, Elena, Villarini, Anna

“…Recent evidence highlights that physical activity (PA) is associated with decreased recurrence risk, improved survival and quality of life for breast cancer…”
Get full text

Effects of a Home-Based Lifestyle Intervention Program on Cardiometabolic Health in Breast Cancer Survivors during the COVID-19 Lockdown by Natalucci, Valentina, Marini, Carlo Ferri, Flori, Marco, Pietropaolo, Francesca, Lucertini, Francesco, Annibalini, Giosuè, Vallorani, Luciana, Sisti, Davide, Saltarelli, Roberta, Villarini, Anna, Monaldi, Silvia, Barocci, Simone, Catalano, Vincenzo, Rocchi, Marco Bruno Luigi, Benelli, Piero, Stocchi, Vilberto, Barbieri, Elena, Emili, Rita

“…This study aimed to evaluate the cardiometabolic effects of a home-based lifestyle intervention (LI) in breast cancer survivors (BCSs) during the COVID-19…”
Get full text

APOLLO 11 Project, Consortium in Advanced Lung Cancer Patients Treated With Innovative Therapies: Integration of Real-World Data and Translational Research by Prelaj, Arsela, Ganzinelli, Monica, Provenzano, Leonardo, Mazzeo, Laura, Viscardi, Giuseppe, Metro, Giulio, Galli, Giulia, Agustoni, Francesco, Corte, Carminia Maria Della, Spagnoletti, Andrea, Giani, Claudia, Ferrara, Roberto, Proto, Claudia, Brambilla, Marta, Dumitrascu, Andra Diana, Inno, Alessandro, Signorelli, Diego, Pizzutilo, Elio Gregory, Brighenti, Matteo, Biello, Federica, Bennati, Chiara, Toschi, Luca, Russano, Marco, Cortellini, Alessio, Catania, Chiara, Bertolini, Federica, Berardi, Rossana, Cantini, Luca, Pecci, Federica, Macerelli, Marianna, Emili, Rita, Bareggi, Claudia, Verderame, Francesco, Lugini, Antonio, Pisconti, Salvatore, Buzzacchino, Federica, Aieta, Michele, Tartarone, Alfredo, Spinelli, Gianpaolo, Vita, Emanuele, Grisanti, Salvatore, Trovò, Francesco, Auletta, Pietro, Lorenzini, Daniele, Agnelli, Luca, Sangaletti, Sabina, Mazzoni, Francesca, Calareso, Giuseppina, Ruggirello, Margherita, Greco, Gabriella Francesca, Vigorito, Raffaella, Occhipinti, Mario, Manglaviti, Sara, Beninato, Teresa, Leporati, Rita, Ambrosini, Paolo, Serino, Roberta, Silvestri, Cecilia, Zito, Emanuela, Pedrocchi, Alessandra Chiara Laura, Miskovic, Vanja, de Braud, Filippo, Pruneri, Giancarlo, Lo Russo, Giuseppe, Genova, Carlo, Vingiani, Andrea

“…Despite several therapeutic efforts, lung cancer remains a highly lethal disease. Novel therapeutic approaches encompass immune-checkpoint inhibitors, targeted…”
Get full text

Feasibility and Efficacy of Autologous Stem Cell Transplantation as First-Line Therapy for Peripheral T-Cell Lymphoma: a Single Center Experience by Falchi, Lorenzo, Gunnellini, Marco, Schippa, Monica, Listorti, Chiara, Gubbiotti, Marta, Emili, Rita, Liberati, Anna Marina

“…Background: Peripheral T-cell lymphomas (PTCL) are a heterogeneous group of aggressive diseases characterized by poor prognosis. At 5 years, only 25 to 45% of…”
Get full text

IHP Interpretation Criteria of Interim-PET Scan Confirms Prognostic Impact In Early Stage Hodgkin Lymphoma Patients without Bulky Disease by Rigacci, Luigi, Zinzani, Pier Luigi, Puccini, Benedetta, Broccoli, Alessandro, Gallamini, Andrea, Merli, Francesco, Stefoni, Vittorio, Stelitano, Caterina, Balzarotti, Monica, Pregno, Patrizia, Brusamolino, Ercole, Salvi, Flavia, Stefani, Pietro Maria, Sancetta, Rosaria, Emili, Rita, Tavera, Silvia, Capodanno, Ida, Vitolo, Umberto, Pellegrini, Cinzia, Liberati, Anna Marina, Bosi, Alberto

“…Abstract 3890 Early stage classical Hodgkin lymphoma (cHL) is highly curable with a combination of chemotherapy and radiotherapy. Nevertheless a small…”
Get full text

Early FDG-PET Scan Confirms Its Prognostic Impact Also in Localized Stage, ABVD Treated Hodgkin Lymphoma Patients by Rigacci, Luigi, Puccini, Benedetta, Merli, Francesco, Stelitano, Caterina, Pregno, Patrizia, Fraulini, Chiara, Salvi, Flavia, Emili, Rita, Capodanno, Ida, Vitolo, Umberto, Chisesi, Teodoro, Levis, Alessandro, Liberati, Anna Marina, Bosi, Alberto

“…Background: Hodgkin's lymphoma is one of the maligant diseases with the highest rate of cure particularly if diagnosed in early stage. Nevertheless a small…”
Get full text

A case of nodular sclerosis Hodgkin’s lymphoma repeatedly relapsing in the context of composite plasma cell‐hyaline vascular Castleman’s disease: successful response to rituximab and radiotherapy by Falchi, Lorenzo, Capello, Daniela, Palumbo, Barbara, Rauco, Annamaria, Emili, Rita, Cianciulli, Michele, Pace, Roberta, Capparella, Vincenzo, Liberati, Fabrizio, Liberati, Anna Marina

“…We report the case of an Epstein‐Barr virus (EBV)‐ and human immunodeficiency virus‐serum negative patient suffering from repeatedly relapsing classical…”
Get full text

Philadelphia Chromosome (Ph') Secondary Clones in Chronic Myeloid Leukemia (CML) Are Not Indicative of Resistance to IFNa- or Imatinib-Based Treatment Regimens by Falchi, Lorenzo, Prontera, Paolo, Luzi, Debora, Festuccia, Viola, Emili, Rita, Gottardi, Enrico, Donti, Emilio, Liberati, Anna Marina

“…The rate of complete karyotypic remission (CKR) and complete molecular remission (undetectable BCR/ABL specific transcript by real-time quantitative-PCR…”
Get full text

Antitumour Activity of Bortezomib-Pegylated Liposomal Doxorubicine Association: Results of an Ongoing Study in Multiple Myeloma Patients by Braccalenti, Giulia, Ferrara, Pasqualinda, Gubbiotti, Marta, Cerroni, Paola, Emili, Rita, Morandi, Maria Grazia, Pace, Roberta, Liberati, Anna Marina

“…Background: There are evidences supporting the existence of a synergism between the proteasome inhibitor bortezomib and anthracyclines. In addition, in vivo…”
Get full text

Persistent Molecular Remission in Patients Treated with Imatinib-IFNa Combination or Imatinib Monotherapy by Schippa, Monica, Gottardi, Enrico, Luzi, Debora, Falchi, Lorenzo, Emili, Rita, Angeletti, Ilaria, Desantis, Giorgia, Gentileschi, Erminia, Cerroni, Paola, Liberati, Anna Marina

“…INTRODUCTION. Continously improving results have been obtained during the last two decades in the control of Philadelphia chromosome (Ph') positive chronic…”
Get full text

Patterns of Clonal Evolution in Ph'-Positive Chronic Myelogenous Leukemia (CML) during Chronic Phase: Overall Incidence, Type, Multiplicity, Development Time, Effect on Subsequent Genetic Instability, Sokal Risk, Type of bcr/abl Transcript and Hematological Evolution by Luzi, Debora, Falchi, Lorenzo, Emili, Rita, Angeletti, Ilaria, Prontera, Paolo, Venti, Giovanna, Bassetti, Alessandra, Gubbiotti, Marta, Capparella, Vincenzo, Gentileschi, Erminia, Donti, Emilio, Liberati, Anna Marina

“…Fifty-two kariotypic abnormalities additional to Philadelphia chromosome (Ph') were documented at the time of diagnosis or during the course of the disease in…”
Get full text

Impact of Complete Kariotypic Remission (CKR) and Sokal Risk on Overall Survival in Chronic Myelogenous Leukemia (CML) Patients: A Monocentric Experience by Falchi, Lorenzo, Schippa, Monica, Luzi, Debora, Emili, Rita, Festuccia, Viola, Giugliano, Emilia, Ardisia, Carmela, Rauco, Annamaria, Pace, Roberta, Donti, Emilio, Liberati, Anna Marina

“…Introduction Progressive improvement has been observed in CKR and survival of CML patients (pts) in response to interferon (IFN)a-based regimens, or imatinib…”
Get full text